French centers tested the calcium-sensitizing inotrope levosimendan in patients with severe but potentially reversible cardiogenic shock recently put on VA-ECMO. Early levosimendan did not facilitate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback